longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Edwards Lifesciences

EW

88.0801.44% ( +1.250 )
Closed: Sep 29, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 50.52, above the reasonable range, cheaper than 4.45% of the time in the past 5 years, and the industry ranks 39/174, the industry Median -0.78.

50.52xP/E
$88.08Stock price
$1.74Earnings per share
50.52xP/E
Stock price$88.08Earnings per share$1.74

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
35.74x
Typical range
11.52x–44.33x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
013263952

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
ISRGUSIntuitive Surgical
46.39x17.25%$145.61B
EWUSEdwards Lifesciences
50.52x38.29%$50.77B
BDXUSBecton Dickinson and
52.62x10.84%$49.57B
IRMDUSiRadimed
47.95x10.67%$1.11B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.